UPDATE 1-AbbVie cancer drug fails two late-stage trials
April 19, 2017 at 19:13 PM EDT
April 19 (Reuters) - AbbVie Inc said on Wednesday that its experimental cancer drug, veliparib, failed to meet the main goals of two late-stage studies.